Login to Your Account



Search

Search results

Clinic Roundup

• Ovascience Inc. , of Cambridge, Mass., suspended enrollment of a trial with Augment, its candidate designed to improve egg quality and increase the success of in vitro fertilization, because the FDA questioned the status of the product as a human c ...

BioWorld Today - Staff - 2013-09-12 00:00 - 0 comments - 0 attachments

Clinic Roundup

Esperion Therapeutics Inc. , of Plymouth, Mich., reported in conjunction with its 2013 year-end results that it plans this month to initiate the ETC-1002-009 phase IIb study of parallel doses of lead compound, ETC-1002, over 12 weeks added to stati ...

BioWorld Today - Staff - 2014-03-07 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Boehringer Ingelheim GmbH , of Ingelheim, Germany, reported results from the phase III STARTVerso 4 trial in patients co-infected with hepatitis C virus (HCV) and HIV, showing that HCV cure 12 weeks (SVR12) after the conclusion of treatment was ach ...

BioWorld Today - Staff - 2014-03-07 01:00 - 0 comments - 0 attachments

Clinic Roundup

• Inovio Pharmaceuticals Inc. , of Blue Bell, Pa., said the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in an 18-patient Phase I trial in chronically hepatitis C virus-infec ...

BioWorld Today - Staff - 2013-10-22 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Roche AG , of Basel, Switzerland, presented new data from the LUTE/VERSE phase IIb studies investigating lebrikizumab in patients with severe uncontrolled asthma. The data showed that asthma attacks were reduced by 60 percent in lebrikizumab-trea ...

BioWorld Today - Staff - 2014-03-06 01:00 - 0 comments - 0 attachments

Clinic roundup

Ico Therapeutics Inc. , of Vancouver, British Columbia, disclosed the final, eight-month patient visit in the phase II iDEAL study. The investigator-sponsored study is evaluating the efficacy and safety of ICO-007 after repeated injections in pat ...

BioWorld Today - Staff - 2014-03-06 01:00 - 0 comments - 0 attachments

Clinic roundup

Boston Therapeutics Inc. , of Manchester, N.H., said it received institutional review board approval to start a phase II study of BTI-320 (formerly PAZ320), a nonsystemic chewable complex carbohydrate-based compound, in the U.S. (BioWorld-To ...

BioWorld Today - Staff - 2014-03-05 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Janssen Pharmaceutica NV , of Beerse, Belgium, part of Johnson & Johnson, reported results from the PROSIPAL (Prevention of Relapse With Oral Antipsychotics Versus Injectable Paliperidone Palmitate) study at the European Congress of Psychiatry ...

BioWorld Today - Staff - 2014-03-05 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Boehringer Ingelheim Corp. , of Ridgefield, Conn., part of Boehringer Ingelheim GmbH, presented data from phase III studies of tiotropium delivered via the Respimat inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of ...

BioWorld Today - Staff - 2014-03-04 01:00 - 0 comments - 0 attachments

Clinic roundup

Chimerix Inc. , of Durham, N.C., released favorable data from presentations at the 2014 BMT Tandem Meetings related to its investigational antiviral with broad-spectrum activity, brincidofovir (CMX001). (BioWorld-Today-2014-03-03) ...

BioWorld Today - Staff - 2014-03-03 01:00 - 0 comments - 0 attachments